by The RxPx Team | Jul 17, 2026 | Articles
Every pharmaceutical launch is measured against ambitious commercial forecasts. Brand teams spend years preparing for approval, market access, and physician uptake. Pharma invests upwards of $1-2 billion and 10+ years to bring a therapy to market. Yet once approved,... by The RxPx Team | Jul 7, 2026 | Articles
How Do We Embrace AI Without Compromising Ethics, Governance, and Trust? That was the central question explored during Medicines Australia’s recent webinar, Conversations & The Code: Compliance and Decision Making – Navigating AI and Emerging... by The RxPx Team | May 26, 2026 | Articles
At Asembia AXS26, one message surfaced repeatedly across conversations with manufacturers, specialty pharmacies, hubs, and patient support leaders: healthcare fragmentation is becoming impossible to ignore. Disconnected systems, siloed vendors, fragmented patient... by The RxPx Team | Nov 26, 2025 | Articles
“Every extra week of delay in treatment can reduce survival rates by up to 8%.” Speed saves lives – yet, across therapeutic areas, delays between diagnosis, prescription, and treatment remain a critical weak point in patient care. Many pharma leaders recognize... by The RxPx Team | Nov 4, 2025 | Articles
At NEXT Pharma Australia 2025, healthcare and life sciences leaders gathered to answer one defining question: How do we integrate artificial intelligence into pharma in a way that’s safe and ethical? This year’s event marked a historic milestone – the first time... by The RxPx Team | Oct 21, 2025 | Articles
“Over 60% of consumers now expect their digital health experience to match their retail experience.” In other words, seamless, responsive, and intuitive. A digital engagement strategy in healthcare can no longer be considered a “nice to have”; it’s the new... 